Marathon Trading Investment Management LLC T Scan Therapeutics, Inc. Transaction History

Marathon Trading Investment Management LLC

$201 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	SELL	$5.85 - $9.51 $218,790 - $355,674	-37,400 Reduced 73.33%	13,600 $79,000
Q1 2024 May 10, 2024	BUY	$4.89 - $8.3 $249,389 - $423,300	51,000 New	51,000 $404,000

Others Institutions Holding TCRX

# of Institutions

Shares Held

41.8M

Call Options Held

Put Options Held

Lynx1 Capital Management LP San Juan, PR

5.22M
Shares

$16 Million
9.31% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5M
Shares

$15.3 Million
1.08% of portfolio
Black Rock Inc. New York, NY

4.46M
Shares

$13.7 Million
0.0% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

4.4M
Shares

$13.5 Million
0.04% of portfolio
Bvf Inc San Francisco, CA

2.99M
Shares

$9.15 Million
0.47% of portfolio

View Full List

About TScan Therapeutics, Inc.

Ticker TCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,929,800
Market Cap $57.9M
Description
TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...

More about TCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account